Of note, alarming results came from a recent study where the murine variant AL002a was chronically administered to 6 months-old 5xFAD mice to study the effect on tau pathology, after the ipsilateral injection of aggregated tau from human AD brains. The gene discussed is MAPT; the disease is Alzheimer disease.